Preserving mitochondrial function prevents the proteasomal degradation of GTP cyclohydrolase I.

Free Radical Biology & Medicine
Shruti SharmaStephen M Black

Abstract

The development of pulmonary hypertension is a common accompaniment of congenital heart disease (CHD) with increased pulmonary blood flow. Our recent evidence suggests that asymmetric dimethylarginine (ADMA)-induced mitochondrial dysfunction causes endothelial nitric oxide synthase (eNOS) uncoupling secondary to a proteasome-dependent degradation of GTP cyclohydrolase I (GCH1) that results in a decrease in the NOS cofactor tetrahydrobiopterin (BH(4)). Decreases in NO signaling are thought to be an early hallmark of endothelial dysfunction. As l-carnitine plays an important role in maintaining mitochondrial function, in this study we examined the protective mechanisms and the therapeutic potential of l-carnitine on NO signaling in pulmonary arterial endothelial cells and in a lamb model of CHD and increased pulmonary blood flow (Shunt). Acetyl-l-carnitine attenuated the ADMA-mediated proteasomal degradation of GCH1. This preservation was associated with a decrease in the association of GCH1 with Hsp70 and the C-terminus of Hsp70-interacting protein (CHIP) and a decrease in its ubiquitination. This in turn prevented the decrease in BH(4) levels induced by ADMA and preserved NO signaling. Treatment of Shunt lambs with l-carnitine ...Continue Reading

References

Aug 1, 1981·Journal of Biomechanical Engineering·C F DeweyP F Davies
Jan 1, 1995·British Journal of Pharmacology·G J SouthanC Thiemermann
Aug 16, 1996·The Journal of Biological Chemistry·S MilstienT I Bonner
Apr 4, 1997·The Journal of Biological Chemistry·B BercovichA Ciechanover
Jan 1, 2000·Cardiovascular Research·R S RonsonJ Vinten-Johansen
Mar 15, 2001·Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Métabolisme·J HoffstedtP Arner
Feb 21, 2002·Proceedings of the National Academy of Sciences of the United States of America·Jiankang LiuBruce N Ames
Dec 26, 2003·American Journal of Physiology. Lung Cellular and Molecular Physiology·Lisa K KellyStephen M Black
Feb 26, 2004·Free Radical Biology & Medicine·Li-Ping Liang, Manisha Patel
Feb 8, 2005·The American Journal of Medicine·Lorenzo A CalòPaul A Davis
Aug 16, 2005·Brain Research. Developmental Brain Research·Mark S WainwrightStephen M Black
Oct 15, 2005·Nature Reviews. Neuroscience·Zane B AndrewsTamas L Horvath
May 11, 2006·American Journal of Physiology. Lung Cellular and Molecular Physiology·Albert C GrobeStephen M Black
May 16, 2006·Journal of Neurochemistry·Lance Swick, Gregory Kapatos
Aug 29, 2006·American Journal of Physiology. Lung Cellular and Molecular Physiology·Dean A WisemanStephen M Black
Sep 11, 2007·American Journal of Physiology. Lung Cellular and Molecular Physiology·Neetu SudStephen M Black
Nov 21, 2007·American Journal of Physiology. Lung Cellular and Molecular Physiology·Shruti SharmaStephen M Black
Apr 1, 2008·Journal of Cellular and Molecular Medicine·Gjumrakch AlievBruce N Ames
Apr 4, 2008·American Journal of Physiology. Cell Physiology·Neetu SudStephen M Black
Jul 23, 2008·Perspectives in Vascular Surgery and Endovascular Therapy·Kimon Bekelis, Nicos Labropoulos
Sep 2, 2008·American Journal of Physiology. Lung Cellular and Molecular Physiology·Peter E OishiStephen M Black
May 19, 2009·American Journal of Physiology. Lung Cellular and Molecular Physiology·Sanjiv KumarStephen M Black
Sep 1, 2009·Advanced Drug Delivery Reviews·Victor A ZammitArduino Arduini
Sep 28, 2010·American Journal of Respiratory Cell and Molecular Biology·Xutong SunStephen M Black

❮ Previous
Next ❯

Citations

Nov 16, 2013·International Journal of Molecular Sciences·Martin L Pall
Apr 1, 2014·Heart, Lung & Circulation·Haiying ChenLe-Xin Wang
May 21, 2015·Pulmonary Circulation·Olga RafikovaStephen M Black
Jan 18, 2019·Antioxidants & Redox Signaling·Ruslan RafikovOlga Rafikova
Aug 13, 2020·Scientific Reports·Maria Del Carmen Asensio LopezDomingo A Pascual Figal
Mar 1, 2015·Molecular Cancer Research : MCR·Christopher S RabenderRoss B Mikkelsen

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Cardiovascular Disease Pathophysiology

Cardiovascular disease involves several different processes that contribute to the pathological mechanism, including hyperglycemia, inflammation, atherosclerosis, hypertension and more. Vasculature stability plays a critical role in the development of the disease. Discover the latest research on cardiovascular disease pathophysiology here.

Related Papers

American Journal of Physiology. Lung Cellular and Molecular Physiology
Sanjiv KumarStephen M Black
Current Pharmaceutical Biotechnology
Alban Latremoliere, Michael Costigan
© 2021 Meta ULC. All rights reserved